Related Experiment Videos

[Stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements]

C Ribbens1, M Malaise

  • 1Université de Liège, Centre hospitalier universitaire du Sart-Tilman, Service de Rhumatologie, Centre d'Etude des Maladies inflammatoires chroniques.

Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|April 4, 2002
PubMed

Insights

Matrix metalloproteinase-3 (MMP-3) is a key enzyme in rheumatoid arthritis joint degradation. Serum MMP-3 may serve as a valuable marker for predicting disease activity and treatment response.

Area of Science:

  • Biochemistry
  • Immunology
  • Rheumatology

Context:

  • Rheumatoid arthritis (RA) involves extracellular matrix degradation.
  • Pro-inflammatory cytokines induce matrix metalloproteinase-3 (MMP-3).
  • MMP-3 activates other metalloproteinases and reflects local inflammation.

Purpose:

  • To evaluate the role of MMP-3 as a marker in rheumatoid arthritis.
  • To assess MMP-3's potential in predicting disease activity and therapeutic response.

Summary:

  • Stromelysin-1 (MMP-3) is crucial in RA extracellular matrix breakdown.
  • Serum MMP-3 levels increase with synovitis and steroid therapy.
  • While not specific to RA, MMP-3 is a useful synovial marker for local inflammation.

Impact:

  • Serum MMP-3 can be a valuable tool for monitoring RA.
  • Early MMP-3 determination may predict disease activity and treatment outcomes.
  • MMP-3 offers a parallel marker to CRP for assessing inflammation in RA.

Related Concept Videos